---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-123108"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:34:57.338395+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Dr. Camille Bedrosian resigns from Rhythm Pharmaceuticals board

## Summary
- Camille L. Bedrosian, M.D. resigned from the Board effective December 16, 2025.
- She served on the Compensation & Management Development and Governance and Nominating Committees.
- Resignation not due to any disagreement with the Company or its operations, policies, or practices.

## SEC filing metadata
- accession: 0001104659-25-123108
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000110465925123108/0001104659-25-123108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000110465925123108/rytm-20251216x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-123108
- JSON: https://secwatch.observer/filing/0001104659-25-123108.json
- Plain text: https://secwatch.observer/filing/0001104659-25-123108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.